id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0044-0008,FDA,FDA-2010-E-0044,"U.S. Patent and Trademark Office to Ube Industries, Ltd. and Mitsubishi Tanabe Pharma Corporation (Birch Stewart & Birch LLP) - Letter",Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T18:14:36Z,,0,0,09000064812bdf8d
FDA-2010-E-0044-0007,FDA,FDA-2010-E-0044,Notice of Final Determination - Letter,Other,Letter(s),2013-01-03T05:00:00Z,2013,1,2013-01-03T05:00:00Z,,2013-01-03T17:11:28Z,,0,0,09000064811a495f
FDA-2010-E-0044-0006,FDA,FDA-2010-E-0044,FDA/CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2011-08-09T19:14:56Z,,0,0,0900006480edc64f
FDA-2010-E-0044-0005,FDA,FDA-2010-E-0044,Determinations of Regulatory Review Periods for Purposes of Patent Extension; BEPREVE,Notice,N-Notice,2010-12-09T05:00:00Z,2010,12,2010-12-09T05:00:00Z,,2024-11-07T22:28:14Z,2010-30991,1,0,0900006480bb2846
FDA-2010-E-0044-0004,FDA,FDA-2010-E-0044,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-06-22T04:00:00Z,2010,6,2010-06-22T04:00:00Z,,2010-06-22T12:41:36Z,,0,0,0900006480b07d20
FDA-2010-E-0044-0003,FDA,FDA-2010-E-0044,"Ube Industries, Ltd. and Mitsubishi Tanabe Pharma Corporation - Patent Term Extension Application",Other,APP-Application,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-08-11T04:37:28Z,,0,0,0900006480a7ffe3
FDA-2010-E-0044-0002,FDA,FDA-2010-E-0044,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:04:45Z,,0,0,0900006480a7ffe0
FDA-2010-E-0044-0001,FDA,FDA-2010-E-0044,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:10:43Z,,0,0,0900006480ab488d